资讯

PharmiWeb58 分钟
AbbVie Acquires Capstan Therapeutics in $2.1B Deal to Advance In Vivo CAR-T Therapies
AbbVie has announced a definitive agreement to acquire Capstan Therapeutics, a clinical-stage biotechnology company, for up ...